search
Back to results

Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars

Primary Purpose

Pulp Disease, Dental

Status
Unknown status
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
Propolis
Mineral Trioxide Aggregate
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pulp Disease, Dental focused on measuring pulpotomy, primary molars, propolis

Eligibility Criteria

5 Years - 8 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Cooperative patient
  2. Healthy 5-8 years old patient with at least one carious primary molar tooth at each side of the patient's mouth.
  3. Presence of at least two-thirds of the root length radiographically.
  4. Restorable tooth.
  5. No signs of hyperemia and hemostasis will be adequately achieved with moistened cotton pellet within 5 minutes after coronal pulp amputation.

Exclusion Criteria:

  1. Teeth showing clinical and radiographic evidence of pulp degeneration such as history of spontaneous or nocturnal pain, tenderness to percussion or palpation, pathologic mobility, swelling or fistulous tract, periodontal ligament (PDL) space widening, internal root resorption, external root resorption, furcal radiolucency/inter- radicular bone destruction and/or periapical bone destruction.
  2. Patients eliciting history of known allergy to pollens associated with propolis.
  3. Parent or guardian refusal to participate.

Sites / Locations

  • Cairo University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Propolis powder

Mineral Tri Oxide

Arm Description

resin (50%), vegetable Balsam, wax essential aromatic oils (30%) salivary secretions (10%) pollen(5%) other substances (5%) including amino acids ,ethanol vitamin A, B complex, and E, minerals, steroids flavonoids. The most important pharmacologically active constituents in propolis are flavonoids, which are well-known compounds which have antioxidant, anti-bacterial, antifungal, antiviral, and anti-inflammatory properties. Other ingredients: carob powder (free flow agent). Contains no yeast, salt, sugar, starch, milk, preservatives or colors.

Consists of calcium oxide and silicon dioxide.When these raw materials are blended, they produce tricalcium silicate, dicalcium silicate, tricalcium aluminate, and tetracalcium aluminoferrite. A radiopacifier (bismuth oxide) is added to the cement for dental radiological diagnosis.

Outcomes

Primary Outcome Measures

Evaluation of postoperative pain after pulpotomy by asking patient and/or parents (binary yes or no)
Binary (yes or no)

Secondary Outcome Measures

Full Information

First Posted
June 9, 2018
Last Updated
July 25, 2019
Sponsor
Cairo University
search

1. Study Identification

Unique Protocol Identification Number
NCT03580135
Brief Title
Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars
Official Title
Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2018 (Actual)
Primary Completion Date
January 2, 2019 (Actual)
Study Completion Date
October 1, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study will be self-funded by investigator and carried out on patients from outpatient clinic in Pediatric Dentistry and Public Health Department- Faculty of Dentistry, Cairo University- Egypt. The procedures will be carried out by postgraduate student Rawda Nader Fathy who has B.D.S. (2011) -Alexandria University- Egypt. The procedures will be carried out on a Knight Midmark Biltmore dental unit (Midmark Corporation 1700 S. Patterson Blvd. Suite 400 Dayton, Ohio 45409, USA) in the post graduate clinic of Pediatric Dentistry and Public Health Department- Faculty of Dentistry, Cairo University- Egypt.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulp Disease, Dental
Keywords
pulpotomy, primary molars, propolis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Propolis powder
Arm Type
Experimental
Arm Description
resin (50%), vegetable Balsam, wax essential aromatic oils (30%) salivary secretions (10%) pollen(5%) other substances (5%) including amino acids ,ethanol vitamin A, B complex, and E, minerals, steroids flavonoids. The most important pharmacologically active constituents in propolis are flavonoids, which are well-known compounds which have antioxidant, anti-bacterial, antifungal, antiviral, and anti-inflammatory properties. Other ingredients: carob powder (free flow agent). Contains no yeast, salt, sugar, starch, milk, preservatives or colors.
Arm Title
Mineral Tri Oxide
Arm Type
Active Comparator
Arm Description
Consists of calcium oxide and silicon dioxide.When these raw materials are blended, they produce tricalcium silicate, dicalcium silicate, tricalcium aluminate, and tetracalcium aluminoferrite. A radiopacifier (bismuth oxide) is added to the cement for dental radiological diagnosis.
Intervention Type
Drug
Intervention Name(s)
Propolis
Other Intervention Name(s)
propolis bee resin
Intervention Description
One and half gram of Standardized Propolis Extract powder (Y.S. Eco Bee Farms Propolis Powder) at 100% was mixed with 1.75 mL of polyethylene glycol (Continental Chemicals, New Delhi, India) to form a thick consistency on a clean dry glass slab with a metal spatula. The paste was carried to the pulp stumps with a metal carrier and then condensed lightly to a thickness of 2 - 3 mm followed by placement of thick mix of GIC to seal the cavity and covered by st.st crown.
Intervention Type
Drug
Intervention Name(s)
Mineral Trioxide Aggregate
Other Intervention Name(s)
MTA
Intervention Description
MTA paste will be prepared as per the manufacturers' instructions to obtain a putty-like consistency. The mixture will be delivered to the pulp stumps and condensed lightly with a moistened sterile cotton pellet to ensure a thickness of 2 to 3 mm. A thick mix of glass ionomer cement (GIC) will applied over the MTA and covered by st.st crown.
Primary Outcome Measure Information:
Title
Evaluation of postoperative pain after pulpotomy by asking patient and/or parents (binary yes or no)
Description
Binary (yes or no)
Time Frame
9 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Cooperative patient Healthy 5-8 years old patient with at least one carious primary molar tooth at each side of the patient's mouth. Presence of at least two-thirds of the root length radiographically. Restorable tooth. No signs of hyperemia and hemostasis will be adequately achieved with moistened cotton pellet within 5 minutes after coronal pulp amputation. Exclusion Criteria: Teeth showing clinical and radiographic evidence of pulp degeneration such as history of spontaneous or nocturnal pain, tenderness to percussion or palpation, pathologic mobility, swelling or fistulous tract, periodontal ligament (PDL) space widening, internal root resorption, external root resorption, furcal radiolucency/inter- radicular bone destruction and/or periapical bone destruction. Patients eliciting history of known allergy to pollens associated with propolis. Parent or guardian refusal to participate.
Facility Information:
Facility Name
Cairo University
City
Cairo
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Time Frame
data will be available within 9 months completion of study
IPD Sharing Access Criteria
data Access will be reviewed by external independent review panel
IPD Sharing URL
http://register.clinicaltrials.gov
Citations:
PubMed Identifier
29607066
Citation
Alolofi H, El-Sayed M, Taha S. Clinical and radiographical evaluation of propolis and thymus vulgaris extracts compared with formocresol pulpotomy in human primary molars. BDJ Open. 2016 Jul 29;2:16005. doi: 10.1038/bdjopen.2016.5. eCollection 2016.
Results Reference
background
PubMed Identifier
28377649
Citation
Hugar SM, Kukreja P, Hugar SS, Gokhale N, Assudani H. Comparative Evaluation of Clinical and Radiographic Success of Formocresol, Propolis, Turmeric Gel, and Calcium Hydroxide on Pulpotomized Primary Molars: A Preliminary Study. Int J Clin Pediatr Dent. 2017 Jan-Mar;10(1):18-23. doi: 10.5005/jp-journals-10005-1400. Epub 2016 Dec 5.
Results Reference
background

Learn more about this trial

Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars

We'll reach out to this number within 24 hrs